BRAZIL POTASH CORP (GRO) Stock Fundamental Analysis

NYSEARCA:GRO • CA10586A1084

2.6 USD
-0.13 (-4.76%)
At close: Feb 20, 2026
2.74 USD
+0.14 (+5.38%)
After Hours: 2/20/2026, 8:04:00 PM
Fundamental Rating

2

Overall GRO gets a fundamental rating of 2 out of 10. We evaluated GRO against 83 industry peers in the Chemicals industry. GRO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GRO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year GRO has reported negative net income.
  • In the past year GRO has reported a negative cash flow from operations.
GRO Yearly Net Income VS EBIT VS OCF VS FCFGRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -45.79%, GRO is doing worse than 95.18% of the companies in the same industry.
  • GRO has a Return On Equity of -47.76%. This is amonst the worse of the industry: GRO underperforms 81.93% of its industry peers.
Industry RankSector Rank
ROA -45.79%
ROE -47.76%
ROIC N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRO Yearly ROA, ROE, ROICGRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for GRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GRO Yearly Profit, Operating, Gross MarginsGRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

6

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, GRO has less shares outstanding
  • GRO has a worse debt/assets ratio than last year.
GRO Yearly Shares OutstandingGRO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GRO Yearly Total Debt VS Total AssetsGRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • An Altman-Z score of 12.37 indicates that GRO is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of GRO (12.37) is better than 100.00% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that GRO is not too dependend on debt financing.
  • GRO has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GRO outperforms 96.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.37
ROIC/WACCN/A
WACCN/A
GRO Yearly LT Debt VS Equity VS FCFGRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that GRO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.09, GRO belongs to the top of the industry, outperforming 83.13% of the companies in the same industry.
  • GRO has a Quick Ratio of 3.09. This indicates that GRO is financially healthy and has no problem in meeting its short term obligations.
  • GRO has a better Quick ratio (3.09) than 91.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.09
GRO Yearly Current Assets VS Current LiabilitesGRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

0

3. Growth

3.1 Past

  • The earnings per share for GRO have decreased strongly by -294.90% in the last year.
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • GRO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.78% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.48%
EPS Next 2Y26.9%
EPS Next 3Y13.3%
EPS Next 5Y7.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRO Yearly Revenue VS EstimatesGRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 2032 200M 400M 600M 800M 1B
GRO Yearly EPS VS EstimatesGRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GRO. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRO Price Earnings VS Forward Price EarningsGRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRO Per share dataGRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • GRO's earnings are expected to grow with 13.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.9%
EPS Next 3Y13.3%

0

5. Dividend

5.1 Amount

  • GRO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BRAZIL POTASH CORP

NYSEARCA:GRO (2/20/2026, 8:04:00 PM)

After market: 2.74 +0.14 (+5.38%)

2.6

-0.13 (-4.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners2.58%
Inst Owner Change661.17%
Ins Owners4.95%
Ins Owner ChangeN/A
Market Cap138.76M
Revenue(TTM)N/A
Net Income(TTM)-66.88M
Analysts80
Price Target3.32 (27.69%)
Short Float %0.37%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-438.37%
Min EPS beat(2)-494.06%
Max EPS beat(2)-382.67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS2.62
TBVpS2.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.79%
ROE -47.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.09
Altman-Z 12.37
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.51%
EPS Next Y-19.48%
EPS Next 2Y26.9%
EPS Next 3Y13.3%
EPS Next 5Y7.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-249.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40.14%
EBIT Next 3Y14.43%
EBIT Next 5Y4.52%
FCF growth 1Y-24.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.56%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZIL POTASH CORP / GRO FAQ

Can you provide the ChartMill fundamental rating for BRAZIL POTASH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to GRO.


What is the valuation status of BRAZIL POTASH CORP (GRO) stock?

ChartMill assigns a valuation rating of 0 / 10 to BRAZIL POTASH CORP (GRO). This can be considered as Overvalued.


What is the profitability of GRO stock?

BRAZIL POTASH CORP (GRO) has a profitability rating of 0 / 10.


What is the financial health of BRAZIL POTASH CORP (GRO) stock?

The financial health rating of BRAZIL POTASH CORP (GRO) is 6 / 10.